BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM • FR0013280286

92.75 EUR
-0.05 (-0.05%)
Last: Feb 13, 2026, 04:11 PM
Fundamental Rating

6

Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 63 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BIM was profitable.
  • In the past year BIM had a positive cash flow from operations.
  • BIM had positive earnings in each of the past 5 years.
  • In the past 5 years BIM always reported a positive cash flow from operatings.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • BIM's Return On Assets of 7.04% is fine compared to the rest of the industry. BIM outperforms 79.37% of its industry peers.
  • With a decent Return On Equity value of 9.61%, BIM is doing good in the industry, outperforming 63.49% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 8.56%, BIM is doing good in the industry, outperforming 69.84% of the companies in the same industry.
  • BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is in line with the industry average of 9.98%.
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROIC 8.56%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 9.17%, BIM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • BIM's Profit Margin has been stable in the last couple of years.
  • BIM has a Operating Margin of 12.38%. This is comparable to the rest of the industry: BIM outperforms 53.97% of its industry peers.
  • BIM's Operating Margin has improved in the last couple of years.
  • BIM's Gross Margin of 56.27% is in line compared to the rest of the industry. BIM outperforms 52.38% of its industry peers.
  • BIM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.38%
PM (TTM) 9.17%
GM 56.27%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BIM is still creating some value.
  • Compared to 1 year ago, BIM has about the same amount of shares outstanding.
  • The number of shares outstanding for BIM has been reduced compared to 5 years ago.
  • BIM has a better debt/assets ratio than last year.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 6.00 indicates that BIM is not in any danger for bankruptcy at the moment.
  • BIM's Altman-Z score of 6.00 is amongst the best of the industry. BIM outperforms 92.06% of its industry peers.
  • The Debt to FCF ratio of BIM is 1.15, which is an excellent value as it means it would take BIM, only 1.15 years of fcf income to pay off all of its debts.
  • BIM's Debt to FCF ratio of 1.15 is amongst the best of the industry. BIM outperforms 85.71% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that BIM is not too dependend on debt financing.
  • BIM's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. BIM outperforms 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Altman-Z 6
ROIC/WACC1.07
WACC8%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.27 indicates that BIM has no problem at all paying its short term obligations.
  • The Current ratio of BIM (2.27) is better than 66.67% of its industry peers.
  • BIM has a Quick Ratio of 1.30. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.30, BIM is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.3
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

  • The earnings per share for BIM have decreased by -8.45% in the last year.
  • The Earnings Per Share has been growing by 10.91% on average over the past years. This is quite good.
  • BIM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.28%.
  • BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%

3.2 Future

  • BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.79% yearly.
  • BIM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.72% yearly.
EPS Next Y15.89%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
EPS Next 5Y11.79%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.72%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.03 indicates a rather expensive valuation of BIM.
  • 68.25% of the companies in the same industry are more expensive than BIM, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, BIM is valued at the same level.
  • BIM is valuated rather expensively with a Price/Forward Earnings ratio of 18.53.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 60.32% of the companies listed in the same industry.
  • BIM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.03
Fwd PE 18.53
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than the industry average as 74.60% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, BIM is valued a bit cheaper than 68.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.02
EV/EBITDA 11.25
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BIM has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as BIM's earnings are expected to grow with 13.50% in the coming years.
PEG (NY)1.51
PEG (5Y)2.2
EPS Next 2Y13.86%
EPS Next 3Y13.5%

4

5. Dividend

5.1 Amount

  • BIM has a yearly dividend return of 0.92%, which is pretty low.
  • BIM's Dividend Yield is a higher than the industry average which is at 0.97.
  • With a Dividend Yield of 0.92, BIM pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.92%

5.2 History

  • On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • BIM pays out 28.07% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of BIM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.07%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (2/13/2026, 4:11:52 PM)

92.75

-0.05 (-0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)03-04
Inst Owners21.47%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap10.98B
Revenue(TTM)4.12B
Net Income(TTM)378.00M
Analysts75.29
Price Target122.03 (31.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.92%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.07%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.92%
PT rev (3m)-4.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.48%
EPS NY rev (3m)-1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.62%
Valuation
Industry RankSector Rank
PE 24.03
Fwd PE 18.53
P/S 2.66
P/FCF 25.02
P/OCF 13.94
P/B 2.79
P/tB 3.93
EV/EBITDA 11.25
EPS(TTM)3.86
EY4.16%
EPS(NY)5
Fwd EY5.4%
FCF(TTM)3.71
FCFY4%
OCF(TTM)6.65
OCFY7.17%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.51
PEG (5Y)2.2
Graham Number53.73
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROCE 11.7%
ROIC 8.56%
ROICexc 9.38%
ROICexgc 13.1%
OM 12.38%
PM (TTM) 9.17%
GM 56.27%
FCFM 10.65%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexgc growth 3Y-22.62%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 73.43%
Cap/Sales 8.46%
Interest Coverage 250
Cash Conversion 79.94%
Profit Quality 116.09%
Current Ratio 2.27
Quick Ratio 1.3
Altman-Z 6
F-Score8
WACC8%
ROIC/WACC1.07
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y15.89%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
EPS Next 5Y11.79%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.72%
EBIT growth 1Y-1.73%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year64.69%
EBIT Next 3Y25.44%
EBIT Next 5Y17.89%
FCF growth 1Y133.53%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.81%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%

BIOMERIEUX / BIM.PA FAQ

What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.


What is the valuation status of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.


What is the profitability of BIM stock?

BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for BIM stock?

The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.


How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?

The dividend rating of BIOMERIEUX (BIM.PA) is 4 / 10 and the dividend payout ratio is 28.07%.